PubMed Health⌕ Search

PubMed · 11020859

Imaging-based dynamic liver testing--a computerized simulation.

Abstract

BACKGROUND/AIMS: The mechanisms for maintaining liver function are complex and currently used liver function tests give limited and often nonspecific and insensitive results. The aim of the study was to demonstrate a dynamic liver test with a tomographic imaging modality as sampling method by means of a computer simulation. METHODOLOGY: A virtual three-dimensional liver model, consisting of parenchyma and bile ducts, was created using computer aided design/computer aided manufacturing software. An intravenously administered, bile excreted test substance was simulated in the model by awarding changing densities to the parenchyma and bile ducts in 12 identical sets of the model. RESULTS: Imaging-based density measurements enabled the creation of time-density curves reflecting the transport of the simulated test substance in the parenchymal mass and bile ducts. By means of quantitative analysis of the curves, parenchymal uptake and excretion and intrahepatic bile flow could be assessed independently. CONCLUSIONS: The method enables comparison of function in different liver segments and may have particular value in investigating diseases that affect the liver in a non-homogeneous fashion, for example primary sclerosing cholangitis. Imaging sampling can theoretically be applied with any tomographic imaging technique for which a suitable test substrate exists, including computed tomography, magnetic resonance imaging or single photon emission tomography.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E Jonas, P Slezak, N Miller. Imaging-based dynamic liver testing--a computerized simulation.. https://pubmed.ncbi.nlm.nih.gov/11020859/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Aminophospholipids have no access to the luminal side of the biliary canaliculus: implications for thr specific lipid composition of the bile fluid.

About 95% of the bile phospholipids are phosphatidylcholine. Although the fractions of phosphatidylcholine and of both aminophospholipids phosphatidylserine and phosphatidylethanolamine in the canalicular membrane are in the same order of about 35% of total lipids, both aminophospholipids are almost absent from the bile. To rationalize this observation, we studied the intracellular uptake of various fluorescent phospholipid analogues and their subsequent enrichment in the bile canaliculus (BC) of HepG2 cells. Diacylaminophospholipid analogues but not phosphatidylcholine analogues became rapidly internalized by an aminophospholipid translocase (APLT) activity in the plasma membrane of HepG2 cells. We observed only low labeling of BC by diacylaminophospholipids but extensive staining by phosphatidylcholine analogues. In the presence of suramin, known to inhibit APLT, a strong labeling of BC by diacylaminophospholipid analogues was found that declined to a level observed for control cells after removal of suramin. Unlike diacylphosphatidylserine, diether phosphatidylserine analogue, which is not an appropriate substrate of APLT, accumulated in the BC. The correlation between low labeling of BC and an APLT-mediated transbilayer movement suggests the presence of an APLT activity in the canalicular membrane that prevents exposure of aminophospholipids to the bile.

Bile↗